Drugs / IL-12 pDNA
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial · 1 missed | ||||||
| Phase 1 | NCT01859325 | May 2013 → Feb 2017 | HIV infectious disease | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | Missed primary |
| Phase not applicable1 trial | ||||||
| — | NCT00323206 | Jun 2004 → Apr 2008 | melanoma | H. Lee Moffitt Cancer Center and Research Institute | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | IL-12p DNA | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00323206 ↗ |
| Modality | Other / unclassified | “type of gene therapy treatment called plasmid electroporation” NCT00323206 ↗ |
| Route | Other | “administered as an intratympanic (IT) injection” NCT00323206 ↗ |